Diabetes Management Market Size - Global Industry, Share, Analysis, Trends and Forecast 2024 - 2032

CHAPTER 1. Industry Overview of Diabetes Management Market

1.1. Definition and Scope

1.1.1. Definition of Diabetes Management

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Diabetes Management Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Diabetes Management Market By Device Type

1.2.3. Diabetes Management Market By Therapeutics

1.2.4. Diabetes Management Market By Application

1.2.5. Diabetes Management Market By End User

1.2.6. Diabetes Management Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Diabetes Management Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Diabetes Management Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Cost Structure Analysis

3.8.1. Price Trend of Key Raw Materials

3.8.2. Raw Material Suppliers

3.8.3. Proportion of Manufacturing Cost Structure

3.8.3.1. Raw Material

3.8.3.2. Labor Cost

3.8.3.3. Manufacturing Expense

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2023

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2023

4.2. R&D Status of Major Manufacturers in 2023

CHAPTER 5. Diabetes Management Market By Device Type

5.1. Introduction

5.2. Diabetes Management Revenue By Device Type

5.2.1. Diabetes Management Revenue (USD Million) and Forecast, By Device Type, 2020-2032

5.2.2. Monitoring Devices

5.2.2.1. Monitoring Devices Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.2.2. Blood Glucose Meters

5.2.2.2.1. Blood Glucose Meters Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.2.3. Lancets

5.2.2.3.1. Lancets Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.2.4. Blood Sampling Devices

5.2.2.4.1. Blood Sampling Devices Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.3. Diagnostic Devices

5.2.3.1. Diagnostic Devices Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.3.2. Hemoglobin A1c

5.2.3.2.1. Hemoglobin A1c Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.3.3. Hemoglobin A1c Kits

5.2.3.3.1. Hemoglobin A1c Kits Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.3.4. Hemoglobin A1c Meters

5.2.3.4.1. Hemoglobin A1c Meters Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.4. Insulin Delivery Devices

5.2.4.1. Insulin Delivery Devices Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.4.2. Insulin Pumps

5.2.4.2.1. Insulin Pumps Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.4.3. Insulin Pens

5.2.4.3.1. Insulin Pens Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.4.4. Disposable Insulin Pens

5.2.4.4.1. Disposable Insulin Pens Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.4.5. Insulin Syringes

5.2.4.5.1. Insulin Syringes Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.4.6. Reusable Insulin Pens

5.2.4.6.1. Reusable Insulin Pens Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.5. Other Devices

5.2.5.1. Other Devices Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.5.2. Artificial Pancreas

5.2.5.2.1. Artificial Pancreas Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.5.3. Commercial Software

5.2.5.3.1. Commercial Software Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.5.4. Software Programs for Diabetes Monitoring

5.2.5.4.1. Software Programs for Diabetes Monitoring Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.5.5. Web Software

5.2.5.5.1. Web Software Market Revenue (USD Million) and Growth Rate (%), 2020-2032

CHAPTER 6. Diabetes Management Market By Therapeutics

6.1. Introduction

6.2. Diabetes Management Revenue By Therapeutics

6.2.1. Diabetes Management Revenue (USD Million) and Forecast, By Therapeutics, 2020-2032

6.2.2. Injectables

6.2.2.1. Injectables Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.2.2. Insulin

6.2.2.2.1. Insulin Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.2.3. Exenatide

6.2.2.3.1. Exenatide Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.3. Oral Drugs

6.2.3.1. Oral Drugs Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.3.2. Metformin

6.2.3.2.1. Metformin Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.3.3. Sulfonylureas

6.2.3.3.1. Sulfonylureas Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.3.4. Alpha glycosidase Inhibitors

6.2.3.4.1. Alpha glycosidase Inhibitors Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.3.5. Dipeptidyl Inhibitors

6.2.3.5.1. Dipeptidyl Inhibitors Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.3.6. Meglitinides

6.2.3.6.1. Meglitinides Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.3.7. Thaizolidinediones

6.2.3.7.1. Thaizolidinediones Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.3.8. Combination Medications

6.2.3.8.1. Combination Medications Market Revenue (USD Million) and Growth Rate (%), 2020-2032

CHAPTER 7. Diabetes Management Market By Application

7.1. Introduction

7.2. Diabetes Management Revenue By Application

7.2.1. Diabetes Management Revenue (USD Million) and Forecast, By Application, 2020-2032

7.2.2. Obesity

7.2.2.1. Obesity Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.3. Diet Management Apps

7.2.3.1. Diet Management Apps Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.4. Diabetes & Blood Glucose Tracking Apps

7.2.4.1. Diabetes & Blood Glucose Tracking Apps Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.5. Others

7.2.5.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032

CHAPTER 8. Diabetes Management Market By End User

8.1. Introduction

8.2. Diabetes Management Revenue By End User

8.2.1. Diabetes Management Revenue (USD Million) and Forecast, By End User, 2020-2032

8.2.2. Specialty Diabetes Clinics

8.2.2.1. Specialty Diabetes Clinics Market Revenue (USD Million) and Growth Rate (%), 2020-2032

8.2.3. Home Healthcare

8.2.3.1. Home Healthcare Market Revenue (USD Million) and Growth Rate (%), 2020-2032

8.2.4. Others

8.2.4.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032

CHAPTER 9. North America Diabetes Management Market By Country 

9.1. North America Diabetes Management Market Overview

9.2. U.S.

9.2.1. U.S. Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032

9.2.2. U.S. Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032

9.2.3. U.S. Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032

9.2.4. U.S. Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032

9.3. Canada

9.3.1. Canada Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032

9.3.2. Canada Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032

9.3.3. Canada Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032

9.3.4. Canada Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032

9.4. North America PEST Analysis

CHAPTER 10. Europe Diabetes Management Market By Country

10.1. Europe Diabetes Management Market Overview

10.2. U.K.

10.2.1. U.K. Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032

10.2.2. U.K. Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032

10.2.3. U.K. Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032

10.2.4. U.K. Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032

10.3. Germany

10.3.1. Germany Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032

10.3.2. Germany Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032

10.3.3. Germany Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032

10.3.4. Germany Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032

10.4. France

10.4.1. France Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032

10.4.2. France Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032

10.4.3. France Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032

10.4.4. France Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032

10.5. Spain

10.5.1. Spain Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032

10.5.2. Spain Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032

10.5.3. Spain Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032

10.5.4. Spain Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032

10.6. Rest of Europe

10.6.1. Rest of Europe Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032

10.6.2. Rest of Europe Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032

10.6.3. Rest of Europe Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032

10.6.4. Rest of Europe Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032

10.7. Europe PEST Analysis

CHAPTER 11. Asia Pacific Diabetes Management Market By Country

11.1. Asia Pacific Diabetes Management Market Overview

11.2. China

11.2.1. China Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032

11.2.2. China Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032

11.2.3. China Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032

11.2.4. China Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032

11.3. Japan

11.3.1. Japan Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032

11.3.2. Japan Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032

11.3.3. Japan Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032

11.3.4. Japan Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032

11.4. India

11.4.1. India Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032

11.4.2. India Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032

11.4.3. India Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032

11.4.4. India Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032

11.5. Australia

11.5.1. Australia Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032

11.5.2. Australia Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032

11.5.3. Australia Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032

11.5.4. Australia Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032

11.6. South Korea

11.6.1. South Korea Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032

11.6.2. South Korea Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032

11.6.3. South Korea Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032

11.6.4. South Korea Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032

11.7. Rest of Asia-Pacific

11.7.1. Rest of Asia-Pacific Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032

11.7.2. Rest of Asia-Pacific Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032

11.7.3. Rest of Asia-Pacific Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032

11.7.4. Rest of Asia-Pacific Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032

11.8. Asia Pacific PEST Analysis

CHAPTER 12. Latin America Diabetes Management Market By Country

12.1. Latin America Diabetes Management Market Overview

12.2. Brazil

12.2.1. Brazil Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032

12.2.2. Brazil Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032

12.2.3. Brazil Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032

12.2.4. Brazil Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032

12.3. Mexico

12.3.1. Mexico Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032

12.3.2. Mexico Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032

12.3.3. Mexico Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032

12.3.4. Mexico Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032

12.4. Rest of Latin America

12.4.1. Rest of Latin America Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032

12.4.2. Rest of Latin America Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032

12.4.3. Rest of Latin America Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032

12.4.4. Rest of Latin America Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032

12.5. Latin America PEST Analysis

CHAPTER 13. Middle East & Africa Diabetes Management Market By Country 

13.1. Middle East & Africa Diabetes Management Market Overview

13.2. GCC

13.2.1. GCC Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032

13.2.2. GCC Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032

13.2.3. GCC Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032

13.2.4. GCC Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032

13.3. South Africa

13.3.1. South Africa Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032

13.3.2. South Africa Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032

13.3.3. South Africa Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032

13.3.4. South Africa Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032

13.4. Rest of Middle East & Africa

13.4.1. Rest of Middle East & Africa Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032

13.4.2. Rest of Middle East & Africa Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032

13.4.3. Rest of Middle East & Africa Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032

13.4.4. Rest of Middle East & Africa Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032

13.5. Middle East & Africa PEST Analysis

CHAPTER 14. Player Analysis Of Diabetes Management Market

14.1. Diabetes Management Market Company Share Analysis

14.2. Competition Matrix

14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

14.2.2. New Product Launches and Product Enhancements

14.2.3. Mergers And Acquisition In Global Diabetes Management Market

14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 15. Company Profile

15.1. Johnson & Johnson

15.1.1. Company Snapshot

15.1.2. Business Overview

15.1.3. Financial Overview

15.1.3.1. Revenue (USD Million), 2023

15.1.3.2. Johnson & Johnson 2023 Diabetes Management Business Regional Distribution

15.1.4. Product /Service and Specification

15.1.5. Recent Developments & Business Strategy

15.2. Dexcom

15.3. Insulet Corporation

15.4. Becton

15.5. Dickinson and Company

15.6. Medtronic

15.7. Roche Diagnostics

15.8. Novo Nordisk

15.9. Eli Lilly and Company

15.10. Abbott Laboratories

15.11. Sanofi